While the mechanisms that potentially drive RAS independence are complex and involve changes in the cancer cells as well as in the tumor microenvironment [92,93], we will focus next on the regulation of YAP/TAZ, as increasing evidence indicates that the activation of these transcriptional co-activators bypasses the need of continued oncogenic RAS signaling in a subset of PDAC. This evidence concerns the gene YAP1 and cancer.